[Evaluation of remicade efficiency for the treatment of rheumatoid arthritis].
The treatment of patients with severe rheumatoid arthritis (RA), who have resistance to basic anti-inflammatory medications (BAIM) has not been always effective. Moreover, a prolonged use of BAIM can cause side effects. Nowadays, REMICADE biological preparation has been used in practical activity by rheumatologists as an inhibitor TNF-alpha. The use of Remicade during 52 weeks gives positive results and improves existence quality of patients with RA.